Catheters Market Size By Product (Vascular Catheters {Cardiovascular Catheters [Electrophysiology Catheters, PTCA Balloon Catheters, IVUS Catheters, PTA Balloon Catheters], Neurovascular Catheters}, Urology Catheters {Dialysis Catheters [Hemodialysis Cath

Catheters Market Size By Product (Vascular Catheters {Cardiovascular Catheters [Electrophysiology Catheters, PTCA Balloon Catheters, IVUS Catheters, PTA Balloon Catheters], Neurovascular Catheters}, Urology Catheters {Dialysis Catheters [Hemodialysis Catheters, Peritoneal Catheters], Urinary Catheters [Indwelling Catheters, Intermittent Catheters, External Catheters]}, Intravenous Catheters {Midline Peripheral Catheters, Peripherally Inserted Central Catheters, Central Venous Catheters}, Specialty Catheters {Wound Catheters, Oximetry Catheters, Thermodilution Catheters}), By Lumen (Single-Lumen, Double-Lumen, Triple-Lumen), By End-use (Hospital, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Covid-19 Impact Analysis, Application Potential, Competitive Market Share & Forecast, 2022 - 2028

The catheters market is projected to expand at a robust pace by 2028 on account of proliferation of ambulatory surgical centers across the globe. Additionally, the expanding geriatric population worldwide is likely to foster market development over the forecast period.



Mounting demand for minimally invasive surgeries and growing incidences of cardiovascular disorders has fueled product adoption. Recent technological advancements in catheters to reduce catheter-based hospital-acquired infections, such as the adoption of silver alloy urinary catheters to prevent catheter-associated urinary tract infections, have augmented industry growth over the past few years.



Furthermore, industry participants have been implementing gainful initiatives to strengthen their foothold in the rapidly evolving marketplace, which has favorably impacted the global business scenario. For instance, in February 2022, Teleflex Incorporated, a prominent manufacturer of medical technologies, received FDA approval for its novel coronary guidewires and specialty catheters for treating patients undergoing total occlusion percutaneous coronary interventions.



The catheters market has been segmented based on end-use, product type, lumen, and region. With respect to product type, the market has been categorized into intravenous catheters, specialty catheters, urology catheters, vascular catheters, and others.



In 2021, the vascular catheters sub-segment held a valuation of around USD 8,804 million and is slated to progress at a CAGR of above 9.6% over the analysis period. This growth is attributed to rising prevalence of cardiovascular diseases and expanding geriatric population.



From the lumen point of view, the catheters market has been bifurcated into triple-lumen, single-lumen, double-lumen, and others. The double-lumen sub-segment exceeded a valuation of USD 8,483 million in 2021 and is set to progress at above 9.9% CAGR through the assessment period. Increasing patient preference for minimally invasive interventional surgeries is estimated to bolster segmental adoption over the forthcoming years.



In terms of end-use, the market has been differentiated into ambulatory surgical centers, hospitals, and others. In 2021, the catheters market share from the hospitals sub-segment was worth about USD 10,911 million and is poised to expand at a CAGR of almost 9.6% between 2022 and 2028. Growing patient preference for hospitals owing to widespread adoption of catheters by hospitals to provide enhanced post-surgical care is speculated to drive segmental development over the following years.



On the regional spectrum, the North America catheters market was valued at about USD 6,655 million in 2021 and is set to grow at more than 7.6% CAGR over the stipulated timeframe. Technological advancements in catheters and supportive government initiatives to promote product adoption in countries across North America are poised to foster market outlook.